The Global Microarrays Market is expected to grow at a CAGR of 7.24% as the demand for drug discovery, disease diagnostics, and precision medicine continues to accelerate.Austin, Texas, Jan. 26, 2026 ...

Pittsburgh, PA — Pitt BioForge and Panther Life Sciences announced the successful completion of BioForge’s first manufacturing project, achieving what had long been considered one of the most ...

NEW YORK – Thermo Fisher Scientific, Genovation Health, and XYGene have signed a multiyear comarketing collaboration agreement aimed at expanding access to integrated genomic solutions, the firms ...

This narrative review reports recent advances in transfusion medicine, encompassing enhancements in molecular diagnostics, blood engineering, and therapeutic technologies. It summarizes findings from ...

Join us for an insightful webinar on the use of polygenic risk scores (PRS) for cardiovascular disease (CVD). The analysis of genetic variation across large populations plays a crucial role in ...

[Image from the Vaxess website] Vaxess Technologies today shared new preclinical data highlighting the capability of its drug delivery patch to deliver semaglutide. Semaglutide, a GLP-1 receptor ...

SOUTH SAN FRANCISCO, Calif. & ANN ARBOR, Mich.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health ...

Large and rare duplications and deletions in a chromosome region known as 22q11.2 , which involves genes that regulate cardiac development, are linked to nonsyndromic bicuspid aortic valve disease, ...

Large and rare duplications and deletions in a chromosome region known as 22q11.2 , which involves genes that regulate cardiac development, are linked to nonsyndromic bicuspid aortic valve disease.